| Common ownership and market entry: Evidence from pharmaceutical industry M Newham, J Seldeslachts, A Banal-Estanol DIW Berlin Discussion Paper, 2018 | 75 | 2018 |
| Changes in common ownership of German companies J Seldeslachts, M Newham, A Banal-Estanol DIW Economic Bulletin 7 (30), 303-311, 2017 | 34 | 2017 |
| Common ownership in the US pharmaceutical industry: A network analysis A Banal-Estañol, M Newham, J Seldeslachts The antitrust bulletin 66 (1), 68-99, 2021 | 16 | 2021 |
| The antitrust case against Apple B Kotapati, S Mutungi, M Newham, J Schroeder, S Shao, M Wang Available at SSRN 3606073, 2020 | 14 | 2020 |
| Do expert panelists herd? Evidence from FDA committees M Newham, R Midjord DIW Discussion Papers, 2020 | 7 | 2020 |
| Adverse effects of acquisitions in the pharmaceutical industry M Newham, KN Vokinger Nature medicine 28 (7), 1342-1344, 2022 | 5 | 2022 |
| Herd behavior in FDA committees: A structural approach M Newham, R Midjord DIW Berlin Discussion Paper, 2018 | 5 | 2018 |
| The cost of influence: How gifts to physicians shape prescriptions and drug costs M Newham, M Valente Journal of Health Economics 95, 102887, 2024 | 3 | 2024 |
| A critical review of South Africa’s Carbon Tax Policy Paper: recommendations for the implementation of an Offset Mechanism M Newham, B Conradie | 3 | 2013 |
| Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen J Seldeslachts, M Newham, A Banal-Estanol DIW Wochenbericht 84 (30), 611-621, 2017 | 2 | 2017 |
| USA und EU setzen auf lokale Impfstoffproduktion: Versorgungssicherheit im Fokus J Malek, M Newham, J Seldeslachts, M Wieting Berlin: Deutsches Institut für Wirtschaftsforschung (DIW), 2020 | 1 | 2020 |
| Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development J Malek, M Newham, J Seldeslachts, R Veugelers DIW Berlin Discussion Paper, 2024 | | 2024 |
| Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten J Seldeslachts, J Malek, M Newham, R Veugelers DIW Wochenbericht 91 (37), 579-585, 2024 | | 2024 |
| Who Pays for Gifts to Physicians? Heterogeneous Effects of Industry Payments on Drug Costs M Newham, M Valente Who Pays for Gifts to Physicians? Heterogeneous Effects of Industry Payments …, 2022 | | 2022 |
| Essays on the Economics of the Pharmaceutical Industry M Newham | | 2021 |
| ‘Killer acquisitions’ en innovatie J Seldeslachts, J Malek, M Newham FD Mediagroep KVS (Koninklijke Vereniging voor de Staatshuishoudkunde)(NL …, 2021 | | 2021 |
| US and EU secure vaccine production on home soil J Malek, M Newham, J Seldeslachts, M Wieting Berlin: Deutsches Institut für Wirtschaftsforschung (DIW), 2020 | | 2020 |
| Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry A Banal-Estañol, M Newham, J Seldeslachts Barcelona School of Economics Working Papers, 2018 | | 2018 |
